Cheuk Hong Leung

Cheuk Hong Leung is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on thoracic oncology, cancer immunotherapy, and radiation oncology, with particular emphasis on lung cancer treatment and immune checkpoint inhibitor mechanisms. His recent work includes characterizing novel anti–CTLA-4 antibodies with peptide masking and non-fucosylation to enhance therapeutic efficacy, analyzing cutaneous immune-related adverse events in melanoma patients, and evaluating postoperative imaging utility after stereotactic brain biopsy. He has also investigated neoadjuvant dual HER2-targeted therapy in early breast cancer and immune checkpoint blockade outcomes in dedifferentiated liposarcomas. His clinical research spans transplant-related pulmonary complications and IDH inhibitor use in recurrent high-grade gliomas.